Analyst
TD Co.
Equibles does not estimate personal net worth.
Joseph Tommy is recorded as Analyst at TD Co.. Joseph Tommy has spoken on 2 earnings calls across 2 companies, most recently for Teva Pharmaceutical Industries Ltd on November 3, 2026. Those appearances were for Teva Pharmaceutical Industries Ltd (TEVA) and Jazz Pharmaceuticals plc (JAZZ). The companies whose calls Joseph Tommy spoke on are classified in the Healthcare sector.
“Just as you're seeing about the LAIs, obviously one of the benefits can be time on therapy and increased compliance. What are you seeing in terms of real-world Busetti refill rates, any kind of patient time on therapy, and has that matched your kind of expectations ahead of launch?”
“You did mention the community setting a couple times, maybe specifically for Xana Datamab. Can you talk about the experience of physicians in the community setting using HER2 targeted agents, maybe in general, and kind of the overall diagnosis strategy there?”
TD Co.
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
